Combination Chemotherapy in Treating Patients With Bladder Cancer

Completed · Phase 3

Conditions studied: Bladder Cancer, Urethral Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether four-drug combination chemotherapy is more effective than two-drug combination chemotherapy in treating bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens in treating patients who have bladder cancer.

Key facts

Study ID
NCT00003701
Run by
Eastern Cooperative Oncology Group
People needed
490
Starts
1999-04-02
Expected to finish
2007-06-15
Last updated by the study team
2023-06-15

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.